Literature DB >> 7428772

Capping of lymphocytes for carrier detection in Duchenne muscular dystrophy: technical problems and a review of the literature.

A D Ho, B Reitter, S Stojakowits, W Fiehn, J Weisser.   

Abstract

There has been considerable interest in capping of lymphocytes in patients with Duchenne muscular dystrophy (DMD). However, the results from different authors are controversial. We have investigated cap formation in thirteen families with DMD, using a method standardized in our laboratory, and could establish diminished capping in all 12 patients and in 12 of the 13 mothers. By examining cap formation simultaneously with whole polyvalent antiserum, with F(ab)2 fragment of polyvalent antiserum, and with monospecific antisera we could also confirm this observation of defective capping in 7 patients and 4 carriers, as compared to 9 control subjects likewise examined. We have indications that treatment of the lymphocytes under unfavourable conditions e.g. preincubation in buffer solution might accentuate the decrease of lymphocyte capping in patients and carriers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428772     DOI: 10.1007/bf00441475

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Concanavalin-A-induced transmembrane linkage of concanavalin A surface receptors to intracellular myosin-containing filaments.

Authors:  J F Ash; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

2.  Lymphocyte capping and carrier detection in Duchenne muscular dystrophy.

Authors:  M E Sands; R Harris
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

3.  Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy.

Authors:  M E Gershwin; R G Taylor; W M Fowler; B Finlayson
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

4.  F(ab')2 reagents are not required if goat, rather than rabbit, antibodies are used to detect human surface immunoglobulin.

Authors:  E L Alexander; S K Sanders
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

5.  Lymphocyte capping in muscular dystrophy.

Authors:  S L Hauser; H L Weiner; M J Bresnan; K A Ault
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

6.  Lymphocyte capping in Duchenne muscular dystrophy.

Authors:  C M Stern; M C Kahan; V Dubowitz
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

7.  Lymphocyte capping in Duchenne muscular dystrophy.

Authors:  N A Pickard; H D Gruemer; W E Nance; B M Goldsmith
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

Review 8.  Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction.

Authors:  G F Schreiner; E R Unanue
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

9.  Lymphocyte capping in carriers of Duchenne muscular dystrophy.

Authors:  P I Bader
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

10.  Lymphocyte capping in carriers of Duchenne muscular dystrophy.

Authors:  V P Sybert; K N Setran; M E Kadin
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

View more
  3 in total

Review 1.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  The genetic status of mothers of isolated cases of Duchenne muscular dystrophy.

Authors:  R J Lane; M Robinow; A D Roses
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

Review 3.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.